Recent Progress in Single-Nucleotide Polymorphism Biosensors
Biosensors · 01.09.2023 · 13 (9) · 864
DOI: 10.3390/bios13090864 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors, online erschienen am 01.09.2023. Verfasst von Kaimin Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou 412007, China. Hauptthemen laut MEDLINE: Autoimmune Diseases, Biosensing Techniques, Cardiovascular Diseases. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Natural Science Foundation of Hunan Province, Hunan Students' Platform for innovation and entrepreneurship training program, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Single-nucleotide polymorphisms (SNPs), the most common form of genetic variation in the human genome, are the main cause of individual differences. Furthermore, such attractive genetic markers are emerging as important hallmarks in clinical diagnosis and treatment. A variety of destructive abnormalities, such as malignancy, cardiovascular disease, inherited metabolic disease, and autoimmune disease, are associated with single-nucleotide variants. Therefore, identification of SNPs is necessary for better understanding of the gene function and health of an individual. SNP detection with simple preparation and operational procedures, high affinity and specificity, and cost-effectiveness have been the key challenge for years. Although biosensing methods offer high specificity and sensitivity, as well, they suffer drawbacks, such as complicated designs, complicated optimization procedures, and the use of complicated chemistry designs and expensive reagents, as well as toxic chemical compounds, for signal detection and amplifications. This review aims to provide an overview on improvements for SNP biosensing based on fluorescent and electrochemical methods. Very recently, novel designs in each category have been presented in detail. Furthermore, detection limitations, advantages and disadvantages, and challenges have also been presented for each type.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunan Key Laboratory of Biomedical Nanomaterials and Devices, Hunan University of Technology, Zhuzhou 412007, China.
Förderung
- The Natural Science Foundation of Hunan Province
- Hunan Students' Platform for innovation and entrepreneurship training program
- Natural Science Foundation of Hunan Province
- Hunan Students’ Platform for innovation and entrepreneurship training program
- Postgraduate Scientific Research Innovation Project of Hunan Province
Zitieren
APA
Wu, K., Kong, F., Zhang, J., Tang, Y., Chen, Y., Chao, L., Nie, L., & Huang, Z. (2023). Recent Progress in Single-Nucleotide Polymorphism Biosensors. Biosensors, 13(9), 864. https://doi.org/10.3390/bios13090864
Vancouver
Wu K, Kong F, Zhang J, Tang Y, Chen Y, Chao L, et al. Recent Progress in Single-Nucleotide Polymorphism Biosensors. Biosensors. 2023;13(9):864. doi:10.3390/bios13090864
BibTeX
@article{Wu2023,
author = {Wu, Kaimin and Kong, Feizhi and Zhang, Jingjing and Tang, Ying and Chen, Yao and Chao, Long and Nie, Libo and Huang, Zhao},
title = {Recent Progress in Single-Nucleotide Polymorphism Biosensors},
journal = {Biosensors},
year = {2023},
volume = {13},
number = {9},
pages = {864},
doi = {10.3390/bios13090864}
}
EUVIMED